Primary Immune Regulatory Disorders (PIRD): Longitudinal Study of Clinical Presentation, Treatment and Outcomes (Peds)
Understanding the Life Course of Primary Immune Regulatory Disorders (PIRD) Patients and Their Family Members
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAU7654
Contact: Jaclyn Dosik: / jd3970@cumc.columbia.edu
Additional Study Information: The purpose of this study is to understand the life course of PIRD patients and their family members that have the same gene change but do not have the same symptoms. PIRD is mostly due to inherited changes in the genes that normally have immune cells fight infections and regulate the immune system. There are many types of problems that patients with PIRD can develop and some can be life-threatening. We do not know the best way to prevent or treat problems with immune system regulation in PIRD patients. We do not know how having PIRD impacts the quality of life of patients and their families. Also, we do not know the health impact on family members with the same gene change. This study aims to learn more about these questions.
This study is closed
Investigator
Olatundun Williams, MD
Do You Qualify?
Have you, your child, or your family member been diagnosed with PIRD (Primary Immune Regulatory Disorders)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Jaclyn Dosik
jd3970@cumc.columbia.edu